Revolution Medicines officer plans $3.2M stock sale

An RVMD officer filed a Rule 144 notice to sell up to 15,448 shares of common stock valued at about $3.2 million.

Rhea-AI Filing Summary

Revolution Medicines, Inc. (RVMD) received a notice under Rule 144 that officer Anthony Mancini plans to sell common stock through Morgan Stanley Smith Barney. The notice covers up to 15,448 shares of common stock, with an aggregate market value of $3,208,240.64, in a transaction expected on September 10, 2026.

Key Figures

Shares to be sold: 15,448 shares Aggregate market value of planned sale: $3,208,240.64 Shares from stock option exercise: 9,363 shares +4 more

7 metrics

Shares to be sold 15,448 shares Maximum RVMD common shares covered by the Rule 144 notice

Aggregate market value of planned sale $3,208,240.64 Estimated value of 15,448 RVMD shares to be sold

Shares from stock option exercise 9,363 shares Common shares underlying options to be exercised on September 10, 2026

Shares from restricted stock units 6,085 shares Common shares from RSUs dated June 15, 2026 to be sold

Shares sold in prior 3 months 4,615 shares RVMD common shares sold on June 16, 2026 by Anthony Mancini

Proceeds from prior sale $720,490.11 Total consideration for 4,615 RVMD shares sold on June 16, 2026

Shares outstanding 214,336,418 shares RVMD common shares outstanding listed in the Rule 144 notice

Key Terms

Rule 144, Exercise of Stock Options, Restricted Stock Units, aggregate market value

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Exercise of Stock Options financial

"Common | 09/10/2026 | Exercise of Stock Options | Issuer"

Restricted Stock Units financial

"Common | 06/15/2026 | Restricted Stock Units | Issuer"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

aggregate market value financial

"Common | Morgan Stanley Smith Barney LLC ... | 15448 | 3208240.64"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

What does the Form 144 filing mean for Revolution Medicines (RVMD)?

The filing states that an officer, Anthony Mancini, intends to sell up to 15,448 shares of RVMD common stock under Rule 144 through a broker. It is a notice of a planned sale by an affiliate, not an action by Revolution Medicines itself.

How many RVMD shares does Anthony Mancini plan to sell under this Form 144?

The notice covers 15,448 shares of Revolution Medicines common stock, with an aggregate market value of $3,208,240.64, to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services.

When is the planned sale of RVMD shares expected to occur?

The planned sale of RVMD common stock reported for Anthony Mancini is indicated with a sale date of September 10, 2026, using Morgan Stanley Smith Barney LLC as broker and listing NASDAQ as the trading market.

What RVMD securities are the source of the shares to be sold?

The filing lists 9,363 shares to be issued from an exercise of stock options dated September 10, 2026, and 6,085 shares from restricted stock units dated June 15, 2026, as the securities to be sold.

Has Anthony Mancini sold RVMD shares in the last three months?

Yes. The filing reports that on June 16, 2026, Anthony Mancini sold 4,615 shares of RVMD common stock for total proceeds of $720,490.11 during the prior three months.

How many RVMD shares are outstanding according to the Form 144?

The notice lists 214,336,418 shares of Revolution Medicines common stock as outstanding, providing context for the planned sale amount under Rule 144.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/10/2026 - 04:39 PM Accepted by SEC EDGAR 09/10/2026 - 04:39 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002124509
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	REVOLUTION MEDICINES INC
SEC File Number	001-39219
Address of Issuer	700 Saginaw Drive Redwood City CALIFORNIA 94063
Phone	6504816801
Name of Person for Whose Account the Securities are To Be Sold	ANTHONY MANCINI
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	15448	3208240.64	214336418	09/10/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/10/2026	Exercise of Stock Options	Issuer			9363	09/10/2026	Cash
Common	06/15/2026	Restricted Stock Units	Issuer			6085	06/15/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ANTHONY MANCINI 700 Saginaw Drive Redwood City CA 94063	Common	06/16/2026	4615	720490.11

144: Remarks and Signature

Remarks
Date of Notice	09/10/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/11/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Anthony Mancini
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)